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Abstract  27 
Context. The Integrated Palliative care Outcome Scale (IPOS) is a widely used tool for assessing 28 
patient needs in palliative care.  29 
Objectives. The aim of this study is to provide a validated version of the patient and staff IPOS for 30 
French-speaking Switzerland (IPOS-Fr) and assess its psychometric properties. 31 
Methods. The validation took place in 12 palliative care units and mobile teams. At baseline (T1) and 32 
three days later (T2), patients’ general health status, palliative care needs (IPOS-Fr) and quality of life 33 
(McGill Quality of Life scale Revised-MQOL-R) were assessed by patients and staff.  34 
Results. We included 173 patients (mean age: 68.8; 92 women; 85% oncologic disease). IPOS internal 35 
consistency was high for the total score (.69 and .71). Staff-patient inter-rater agreement was good to 36 
moderate for 13 items (intra-class correlations >.516). Results indicated strong correlations between 37 
IPOS-Fr and MQOL-R for the total score (-.623 at T1) and the psychological domain (item 11:-.601 at 38 
T1; item 13: -.633 at T2). Regarding sensitivity to change, there was a significant difference between 39 
T1 and T2 for patients with an improved health condition (z=-2.326; p=.020).  40 
Conclusion. IPOS-Fr has fair to good validity, especially with regard to inter-rater agreement and 41 
construct validity, is sensitive to positive change, and has good interpretability and acceptability for 42 
patients and staff. IPOS-Fr is not optimal in terms of internal consistency and structure when using 43 
subscale scores, except for the emotional subscale.  44 
 45 
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Introduction 49 
The Palliative care Outcome Scale (POS) was designed for evaluating essential outcomes in palliative 50 
care, and has demonstrated validity(1). The Integrated Palliative care Outcome Scale (IPOS)(2), an 51 
advancement of POS(3), is composed of 10 questions and exists in patient and staff versions, to be 52 
completed within a 3 or 7-day recall period. IPOS embraces a holistic perspective by evaluating patients’ 53 
physical, emotional, spiritual, and communicational needs. A Rasch analysis of IPOS supported its use 54 
as a clinical and research measure(4).  55 
IPOS’s 17 items are scored with a Likert scale (from "0", not affected, to "4", extremely affected). For 56 
items 14-16, the Likert scale options were reversed and data was re-scaled. According to the POS 57 
development team, items can be considered independently, as subscales (physical symptoms, items 58 
1-10; emotional symptoms, items 11-14; problems and communication, items 15-17), or summed to 59 
yield a total score (range 0-68). Open comments about additional symptoms, a question assessing how 60 
the patient filled the questionnaire, and the staff Likert option “cannot assess” are not considered for 61 
score calculation. 62 
IPOS already has several translations(2, 5-6). French is ranked the fifth most widely spoken language 63 
in the world(7). Having already performed its cross-cultural adaptation to French(7,8), our aim was to 64 
provide a psychometrically validated version of IPOS in French (IPOS-Fr).  65 
Methods 66 
Participants and procedure 67 
The study was performed between January 2017 and February 2018 in seven palliative care units 68 
(PCUs) and five mobile palliative care teams in French-speaking Switzerland. Inclusion criteria were 69 
patients ≥18 years old, good comprehension of French, stable condition over the past day. Exclusion 70 
criteria were impaired mental capacity according to the clinical judgement of the referring physician or 71 
existing diagnosis and evidence of psychiatric disease affecting decision-making capacity.  72 
Eligible patients provided informed consent and filled IPOS-Fr three or more days after admission for 73 
palliative treatment (T1). In parallel, staff IPOS-Fr was completed by a referring palliative specialist 74 
(physician, nurse, psychologist, or specialized nursing auxiliary). If possible, a second assessment was 75 
performed three days after (T2). 76 
Missing data strategies 77 
Psychometric analysis was performed according to seven scenarios for dealing with missing data (MD), 78 
and estimated that the best strategy for calculating subscale and total score was the subscale median 79 
imputation for up to one MD per subscale (see table 1 supplementary material). Admitting more MD 80 
would require too much interpretation. This strategy allowed to include most participants (169/160 valid 81 
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cases at T1 for patients/staff, 108/102 at T2) and corresponded to the non-normal distribution of the 82 
dataset (after performing the Shapiro-Kolmogorov test). 83 
[Insert table 1 supplementary material-Scenarios for dealing with MD] 84 
Reliability 85 
For reliability measures we considered only values at T1, given that at T2 patients might have been 86 
biased by prior knowledge of the items. The internal structure of patient and staff IPOS-Fr was tested 87 
with a factorial analysis using varimax rotation. The internal consistency of patient and staff IPOS-Fr 88 
versions was measured by calculating Cronbach's alpha for the total scales at T1 and for the factors 89 
revealed in the factorial analysis. Cronbach alpha was recalculated by excluding each item one at a 90 
time, in order to evaluate the precise influence of each item on the identified subscale. Acceptable 91 
values range from 0.7 to 0.95(9). We then compared these results with the Cronbach's alphas 92 
calculated from the subscales proposed by the original version. 93 
For inter-rater agreement, we calculated intraclass correlations (ICC) between IPOS-Fr staff and patient 94 
scores at T1 on individual and subscale scores. Using the averaged reliability of different raters, we 95 
considered values <0.5, between 0.5 and 0.75, between 0.75 and 0.9, and >0.9 as indicative of poor, 96 
moderate, good, and excellent reliability(10).  97 
Construct validity 98 
Construct validity was tested through Pearson correlations between IPOS and the McGill Quality of Life 99 
scale-Revised version (MQOL-R). It contains 14 items forming four subscales: physical, psychological, 100 
existential, and relationship. We checked correlations between IPOS individual and total scores, and 101 
MQOL-R subscale and total scores. We considered values r>.50 as indicator of strong to exceptional 102 
association; .40<r<.50 as indicator of medium association; and r<.40 as indicator of poor to inexistent 103 
association(11). We expected negative correlations since IPOS-Fr displays need for palliative care and 104 
MQOL-R displays patients’ quality of life.  105 
Sensitivity to change 106 
We compared the consistency of patient and staff IPOS-Fr scores at T1 and T2 with the consistency of 107 
their evaluation of the patients’ condition ("How do you evaluate your general health state?") using 108 
Wilcoxon's non-parametric test. This allowed categorizing patients in a "stability", "improvement", or 109 
"deterioration" group. The hypothesis was that IPOS-Fr score would not change for patients of the 110 
“stability” group, but would for the others.  111 
Interpretability and acceptability 112 
These two aspects were assessed through analysis of the free text in IPOS-Fr comments and through 113 
measure of required time to complete IPOS-Fr.  114 
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Ethics 115 
The study was approved by the Research Ethics Committee of the canton of Vaud, Switzerland, with 116 
patients’ written agreement. 117 
Results 118 
Descriptive results 119 
173 patients and 169 staff completed IPOS-Fr at T1, and 108 patients and 102 staff at T2. The 120 
difference in numbers between T1 and T2 is due to worsening state or departure (see table 2 121 
supplementary material). Recruitment and participation was higher in PCUs.  122 
[Insert table 2 supplementary material-Participants' characteristics] 123 
At baseline, mean item scores ranged from 0.4 for item 5 to 2.3 for item 12 for patients, and from 0.3 to 124 
2.5 for the same items for staff (see table 1).  125 
[Insert table 1-Mean symptom intensity and scores] 126 
Missing data 127 
At T1, 78% of patient and 69% of staff had no MD; at T2, 60% and 72% respectively (see table 3 128 
supplementary material).  129 
[Insert table 3 supplementary material-MD at T1 and T2] 130 
Items 12, 15, and 17 had most MD; the first two were highlighted during the cross-cultural adaptation 131 
as potentially difficult to understand(8) (see table 4 supplementary material).  132 
[Insert table 4 supplementary material-Frequency of MD ] 133 
Reliability 134 
Internal structure 135 
The factorial analysis with varimax rotation revealed six factors with an eigenvalue ≥1 explaining 61% 136 
of the total variance for patient IPOS-Fr, and five such factors explaining 59% for staff IPOS-Fr (see 137 
table 5 and 6 supplementary material). The three-subscale pattern of IPOS was not confirmed. 138 
However, for patients factor 4 is identical to the problems and communication subscale and for staff, 139 
factor 1 to the emotional subscale. 140 
[Insert table 5 supplementary material-Factorial analysis] 141 
[Insert table 6 supplementary material-Correlations between IPOS-Fr items and factors] 142 
6 
 
Internal consistency 143 
Cronbach's alpha was .69 and .71 for total scores. Cronbach’s alpha for factors 4, 5, and 6 for patients 144 
and 4 and 5 for staff were lower than .70. No single item was essential to guarantee the subscales’ 145 
consistency (see table 7 supplementary material). 146 
[Insert table 7 supplementary material-Cronbach’s alpha for factors] 147 
For the subscales, Cronbach's alpha varied between .34 and .81 (see table 8 supplementary material).  148 
[Table 8 supplementary material-Cronbach's alpha for subscales] 149 
Inter-rater consistency 150 
ICC coefficients indicated good reliability for item 2, moderate for items 1, 3-7, 9-11, 13, 14, 17, and for 151 
the three subscales, and poor for items 8, 12, 15, 16 (see table 9 supplementary material).  152 
[Insert table 9 supplementary material-Intra-class correlations] 153 
Construct validity 154 
At T1, our results indicate strong correlations between MQOL-R and patient IPOS-Fr for the total score, 155 
the psychological domain (IPOS-Fr item 11 and 13), and the social subscale (item 15). At T2, 156 
correlations were medium to weak for the physical subscale, the existential domain (IPOS-Fr item 14) 157 
and the social domain (IPOS-Fr item 15) (see table 10 supplementary material). 158 
[Insert table 10 supplementary material-Pearson's correlations] 159 
Sensitivity to change 160 
The data show a significant difference between T1 and T2 for the "improvement" group, but not for the 161 
“stability” and "deterioration" groups (see table 11 supplementary material).  162 
[Insert table 11 supplementary material-Sensitivity to change ] 163 
Mobile team vs PCU setting 164 
Regarding Cronbach's alpha, in the mobile team setting patient IPOS-Fr systematically scored lower 165 
than in PCU; for staff, it was the opposite. Stronger ICC correlations were found for the emotional 166 
subscale (PCUs) and the problems and communication subscale (mobile team). Correlations between 167 
IPOS-Fr and MQOL-R did not change for PCUs while for the mobile setting the only significant 168 
correlations were between MQOL-R psychological subscale and item 13 (T1 and T2) and 11 (at T1).  169 
Interpretability and acceptability 170 
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Patients completed IPOS-Fr in one day, mostly in one time (97% at T1), in less than 20 minutes (68%), 171 
aided by staff (56% at T1).  172 
At T1 and T2, 45 patients made overall comments regarding IPOS-Fr: 23 noted its usefulness and 173 
clarity, while 33 made precisions concerning the assessment of symptoms.  174 
At T1 and T2, 20 staff members reported comments about IPOS-Fr. Three noted that questions are 175 
useful and interesting. Four considered IPOS-Fr too long or inadequate for patients, three found the 176 
Likert scale imprecise, seven noted the difficulty in evaluating items, three suggested more attention to 177 
goals of care.  178 
Discussion 179 
Our study reports results on IPOS-Fr's psychometric validation based on a large sample of patients 180 
representative of the French-speaking palliative care context.  181 
Regarding IPOS's internal reliability, the three-subscale structure of the original IPOS was not, 182 
originally, backed by a psychometric validity and was not confirmed by a Rasch analysis that highlighted 183 
the existence of several “super-items”(3). The factorial analysis that we performed on patient and staff 184 
IPOS-Fr revealed six and five main factors, respectively, and therefore did not confirm the three 185 
subscale structure of IPOS, even though factor 4 for patients corresponded to the problems and 186 
communication subscale (items 15-17) and factor 1 for staff corresponded to the emotional subscale 187 
(items 11-14). While some items could be removed in order to create new subscales, this is impossible 188 
due to their clinical importance but also because as a translated version, IPOS-Fr cannot significantly 189 
differ in items from the original version. Regarding our factors, additional elements do not speak in favor 190 
of their validity: (i) the fact that the reduction of the information is not very important (from 17 items to 6 191 
and 5 factors respectively, leaving approximately 40% of the variance unexplained), (ii) the 192 
heterogeneity of the items’ number per factor, (iii) the fact that a common point between items is 193 
sometimes difficult to highlight, and (iv) finally the fact that several factors clearly focus on the same 194 
aspect (three factors concern the physical area in both IPOS patient and staff). 195 
In addition, when looking at the internal consistency of our factors, half of them showed insufficient 196 
values (below .45) from the patient IPOS-Fr, which is also a reason not to recommend the use of our 197 
subscales. Similar results were obtained with the staff IPOS-Fr. Results were better when considering 198 
the internal consistency calculated from the original three-subscale structure but, once again, this 199 
structure was not confirmed by our factorial analysis. We therefore conclude that the use of any 200 
subscale is not advisable for IPOS-Fr and we recommend the use of either the total score or individual 201 
items.  202 
In terms of inter-rater agreement, our results showed that staff and patient views on symptoms and 203 
outcomes are globally similar, except for item 8 (“sore or dry mouth”), two items involving the relatives 204 
(items 12 “anxiety of close ones” and 15 sharing of feelings”), and interestingly, the item 16 assessing 205 
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the satisfaction with the transmitted information. Differences in staff and patient interpretation were 206 
revealed during the adaptation phase(8). 207 
In terms of construct validity, similar to the POS(1) and its translations(12; 13), IPOS showed good 208 
patient-staff agreements. Patient IPOS-Fr showed strong correlations(11) with the MQOL-R for the total 209 
score and the psychological domain. Weaker but still moderate correlations were found for the physical 210 
domain, the existential domain, and the social domain at T2. These lower correlations may be explained 211 
by the fact that IPOS-Fr does not allow for a complete and in-depth evaluation of these dimensions, 212 
except perhaps for the emotional dimension which evaluates both depression and anxiety outcomes, 213 
the most frequent psychiatric manifestations in the palliative care context(14). 214 
Results showed that patient and staff IPOS-Fr are sensitive enough to detect improvement of patient's 215 
condition. This is encouraging knowing that the formed groups have a relatively similar profile in terms 216 
of palliative care needs and that there is overall little evolution of their health state. As reflected through 217 
the difference in patient population at T1 and T2, it remains challenging to assess sensitivity to change 218 
in this context.  219 
Results in terms of interpretability and acceptability are rather encouraging within this francophone 220 
population and their staff. Nevertheless, its clinical applicability might be affected by the fact that some 221 
specific items showed more missing data than others (items 12, 15, 17) and that most patients required 222 
the aid of a member of the staff. Moreover, the clinical applicability might also be affected by the context, 223 
as mobile teams reported more difficulty than PCUs in recruiting patients (only 18% of patients were 224 
recruited through mobile teams) and in ensuring that the questionnaire was filled in on the same day by 225 
patient and staff. A possible cause of this disparity resides on the fact that mobile teams are smaller, 226 
and therefore had less opportunities for ensuring that, during an intervention, one professional can aid 227 
the patient to complete the IPOS patient and another one can fill in the IPOS staff. In addition, most of 228 
the time, mobile teams intervene in critical moments, so fewer of their patients met the "stability" 229 
inclusion criteria. 230 
This study has several limitations. First, we had to employ a missing data strategy, which requires a 231 
degree of interpretation. Tolerating one MD per subscale meant that the total score was calculated with 232 
up to three MD, which is not optimal because it means that we have accepted up to 17.5% of MD (3 233 
items on 17 in total). Second, we could only include patients who had been in a stable condition over 234 
the past day, generating a selection bias and floor effect in a pool of relatively well-faring patients. Scant 235 
data for the mobile context and lack of inclusion of other settings limit the generalizability of the results. 236 
Conclusions 237 
IPOS-Fr demonstrated fair to good inter-rater agreement and construct validity, is sensitive to positive 238 
change, and has good interpretability and acceptability. IPOS-Fr is not optimal in terms of internal 239 
consistency and structure when using subscale scores. We recommend the use of total or single item 240 
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scores in both research and clinical settings. Health care professionals should be familiar with this tool, 241 
but also aware of its limitations. 242 
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